Loading...
Loading...
Zacks Investment Research has initiated coverage on Icad
ICAD with a Neutral rating and $1.30 price target.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Price TargetInitiationAnalyst RatingsHealth CareHealth Care TechnologyZacks investment research
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
